(Reuters) – British bootmaker Dr Martens said on Thursday it will reduce discounts in the Americas and EMEA regions in the current financial year and expects adjusted pre-tax profit to be in line with market expectations.
The Trump administration’s steep tariffs on trade partners have significantly increased supply costs for companies like Dr Martens. Since most of its products are made in Vietnam, the company now faces a 46% reciprocal tariff, set to take effect in July.
However, the firm said it will keep average selling prices for its spring/summer and autumn/winter collections unchanged in the U.S. market as it continues to tighten costs and assess the impact of tariffs.
For the year ended March 2025, Dr Martens logged an adjusted pre-tax profit of 34.1 million pounds ($46.2 million), above analysts’ consensus of 30.6 million pounds, as per a company-compiled poll.
(Reporting by Raechel Thankam Job in Bengaluru; Editing by Janane Venkatraman and Sonia Cheema)
Comments